Clinical trials support ILUMYA for psoriatic arthritis

Top-line findings from two Phase 3 clinical trials assessing the safety and effectiveness of tildrakizumab 100 mg (ILUMYA) given over a 24-week period for the treatment of active psoriatic arthritis were released today by Sun Pharmaceutical

India to Align Pharma Cleanroom Standards with WHO Guidelines

India is going to change the microbial contamination limits as per Schedule M in the Drugs and Cosmetics Rules to the global WHO limits in a major initiative to improve pharmaceutical manufacturing standards. The decision was taken at the Drugs...

Kerala's Kozhikode Launches Free Glucose Monitors for Diabetic Kids

In a breakthrough for health care, Kozhikode has become the first district in Kerala to provide continuous glucose monitoring (CGM) systems free of charge to children diagnosed with Type 1 Diabetes (T1D)...

India Developing Multi-Stage Malaria Vaccine Named 'AdFalciVax'

Indian Council of Medical Research (ICMR), along with Regional Medical Research Centre, Bhubaneswar (RMRCBB) and National Institute of Malaria Research (NIMR) is leading the formulation of a new indigenous malaria vaccine called AdFalciVax.

Torrent Pharma Plans Rs 19,500 Cr Deal to Acquire JB Chemicals

Torrent Pharmaceuticals has sought the Competition Commission of India (CCI) clearance for its planned ?19,500 crore acquisition of a majority holding in JB Chemicals & Pharmaceuticals.

Venus Remedies Secures WHO GDP for Top-Tier Drug Distribution

Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven pharmaceutical company, has once again received the World Health Organization (WHO) Good Distribution Practices (GDP)

Biocon Biologics Gains Edge with FDA Nod for Kirsty Insulin

Biocon Biologics has announced US FDA approval for Kirsty (Insulin Aspart-xjhz, 100 units/mL). It's an extremely important development as Kirsty is the first and only interchangeable biosimilar to NovoLog, a rapid-acting insulin brand...

CDSCO Pushes COPP Application Deadline for Pharma Firms to Aug 15

The Central Drugs Standard Control Organisation (CDSCO) further prolonged the deadline for pharma firms to file online applications for the WHO Good Manufacturing Practices (GMP) Certificate of Pharmaceutical Product (COPP) to August 15, 2025.

Danaher India and THSTI Unite to Scale Biomanufacturing in India

The critical momentum to the biomanufacturing sector in India is being spurred by the fact that Danaher India, a subsidiary of world science and technology giant Danaher Corporation, has entered into a strategic alliance with the Translational Health

New Agilent Pro iQ Series Enhances LC-MS Detection in India

The InfinityLab Pro iQ Series mass detectors were launched by Agilent Technologies in India. The series is designed for next-generation liquid chromatography-mass detection (LC-MS) and aims to improve how impurities, trace contaminants, and complex

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.